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B I O C H E M I S T R Y
Integrator restrains paraspeckles assembly by 
promoting isoform switching of the lncRNA NEAT1
Jasmine Barra1,2,3,4,5, Gabriel S. Gaidosh6, Ezra Blumenthal6, Felipe Beckedorff 6, Mina M. Tayari6, 
Nina Kirstein6, Tobias K. Karakach7,8, Torben Heick Jensen9, Francis Impens3,4,10, Kris Gevaert3,4, 
Eleonora Leucci5*, Ramin Shiekhattar6*, Jean-Christophe Marine1,2*†
RNA 3′ end processing provides a source of transcriptome diversification which affects various (patho)-physiological 
processes. A prime example is the transcript isoform switch that leads to the read-through expression of the long 
non-coding RNA NEAT1_2, at the expense of the shorter polyadenylated transcript NEAT1_1. NEAT1_2 is required 
for assembly of paraspeckles (PS), nuclear bodies that protect cancer cells from oncogene-induced replication stress 
and chemotherapy. Searching for proteins that modulate this event, we identified factors involved in the 3′ end 
processing of polyadenylated RNA and components of the Integrator complex. Perturbation experiments estab-
lished that, by promoting the cleavage of NEAT1_2, Integrator forces NEAT1_2 to NEAT1_1 isoform switching and, 
thereby, restrains PS assembly. Consistently, low levels of Integrator subunits correlated with poorer prognosis of 
cancer patients exposed to chemotherapeutics. Our study establishes that Integrator regulates PS biogenesis and 
a link between Integrator, cancer biology, and chemosensitivity, which may be exploited therapeutically. 
INTRODUCTION
Most human genes have multiple sites at which RNA 3′ end cleavage 
and polyadenylation can occur (1). Alternative 3′ end cleavage gives 
rise to transcript isoforms that differ either in their coding sequences 
or in their 3′ untranslated regions (UTRs) and, thus, contribute to 
transcriptome diversification (1, 2). Remodeling of 3′ UTRs can have 
particularly profound phenotypic consequences; hence, transcript 
isoforms may differ in their relative stability, localization, translation 
rate, and/or function (2). Although it is well known that RNA 3′ end 
processing can be finely regulated depending on the cellular needs, 
the factors involved in alternative 3′ end processing are only partially 
characterized.
The core of the pre-mRNA 3′ end processing complex consists of 
four subcomplexes, namely, cleavage and polyadenylation factor (CPSF), 
cleavage stimulation factor (CSTF), cleavage factor I (CFI), and CFII. 
Few other proteins, including symplekin and polyadenylate [poly(A)] 
polymerase (PAP), are also involved in completing the 3′ end for-
mation of polyadenylated RNA (3). In metazoans, sites of pre-mRNA 
polyadenylation are primarily defined by the canonical poly(A) signal 
AAUAAA, which is positioned ~21-nucleotides (nt) upstream of the 
cleavage site (3). This hexamer is recognized by the cotranscriptionally 
recruited CPSF subcomplex, which carries out the endonucleolytic 
cleavage event, followed by the addition of a poly(A) tail to the 
5′ cleavage product by PAP. Deregulation of protein expression levels 
and/or activity of core 3′ end processing factors can obviously con-
tribute to 3′ end processing rewiring, either globally or specifically, 
and thereby affect transcriptome diversification in response to specific 
environmental cues. Moreover, many other RNA binding proteins 
can influence RNA 3′ end processing, often depending on the binding 
positions within mRNA target 3′ UTRs (4).
Other protein complexes are involved in the 3′ end processing of 
nonpolyadenylated RNA species. For instance, the Integrator com-
plex, which binds to the C-terminal domain (CTD) of the RNA 
polymerase II (Pol II), is responsible for the RNA 3′ end processing 
of uridylate-rich small nuclear RNA transcripts (UsnRNAs) (5). This 
complex has been shown to control termination of transcription 
and 3′ end processing at enhancer RNAs and replication-dependent 
histone loci (6, 7). Furthermore, Integrator binding to the proximal 
promoter region of polyadenylated target genes negatively regulates 
their expression (7).
Alternative 3′ end processing–dependent transcriptome diversi-
fication plays key roles in various important biological processes (4). 
Individual 3′ end processing events have also been implicated under 
pathological conditions, including autoimmune disorders and cancer 
(4). Consistent with a reported general association between the ex-
pression of short RNA 3′ UTRs and a proliferative cellular state (8), 
most cancers express transcripts with shorter 3′ UTRs than those 
expressed in corresponding normal tissues (4). Some studies have 
attributed cancer-related 3′ end RNA patterns to the deregulated 
activity of specific 3′ end processing factors, such as CSTF2 (9) and 
CFIm25 (10). However, the motifs recognized by these core 3′ end 
processing factors do not explain the observed quantitative changes 
in poly(A) site usage between tumor and normal tissue samples from 
The Cancer Genome Atlas (TCGA) (11), indicating that other un-
known modulators also contribute.
Deregulation of RNA 3′ end processing at specific loci may also 
contribute to tumor growth as illustrated in recent findings implicating 
the long noncoding RNA (lncRNA) locus NEAT1 in cancer devel-
opment (12). This locus produces two lncRNA isoforms (13). The 
shorter isoform, NEAT1_1 (3700 nt in length), contains a functional 
poly(A) site. The long NEAT1_2 isoform (22700 nt in length), which 
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is not polyadenylated, is produced as a read-through transcript when 
the 3′ end processing of NEAT1_1 is inefficient (14). The mechanisms 
underlying NEAT1 isoform switching remain poorly understood. The 
ubiquitous heterogeneous nuclear ribonucleoprotein K (HNRNPK) 
has been implicated in this process, by competing with CPSF6 for the 
binding of NUDT21 (CFIm25) and impairing NEAT1_1 polyadenylation 
(14). Moreover, TAR DNA binding protein 43 (TDP-43) enhances 
NEAT1_1 polyadenylation in pluripotent cells (15). Whereas the 
function of NEAT1_1 still needs to be established (16, 17), NEAT1_2 
is an essential architectural component of paraspeckles (PS) (18), 
which are highly ordered and phase-separated nuclear stress bodies 
(19). Thus, PS assembly critically depends on the poorly understood 
NEAT1 isoform switch. Expression of NEAT1_2, and thereby PS 
assembly, can only be detected under specific physiological condi-
tions (i.e., lactating mammary glands) and in response to various 
forms of stresses, including oncogenic stress (12, 20–22). Accordingly, 
PS appear in over 65% of human epithelial cancers (12), where they 
predict poor prognosis (23) and are either completely absent, or only 
sporadically detectable, in normal tissues (12, 24). In a classical 
two-stage chemically induced skin cancer mouse model, PS are induced 
in skin epidermal cells exposed to oncogenic stress, while genetic 
ablation of NEAT1 markedly impairs tumor initiation and progression 
into aggressive and invasive lesions (12). However, mouse skin that 
lacks only the short Neat1_1 isoform does not exhibit these protective 
properties (17). Critically, specific down- regulation of NEAT1_2 
using antisense oligonucleotides sensitized a series of epithelial can-
cer cell lines to various clinically relevant anticancer therapeutics 
(12). Hence, these studies identified NEAT1_2, and by extension PS, 
as promising cell-specific therapeutic targets for the chemosensiti-
zation of a wide range of epithelial cancers. We therefore reasoned 
that a better understanding of pathways and factors/enzymes in-
volved in the molecular mechanisms underlying NEAT1 isoform 
switching and, thereby, PS biogenesis may lead to the identification 
of targets that are amenable to conventional therapeutics.
RESULTS
Identification of Integrator as a previously unknown  
NEAT1 RNA interactor
To identify proteins that modulate NEAT1_2 expression and conse-
quently PS biogenesis, we adapted the RNA antisense purification 
(RAP) protocol we previously used to identify interactors of the 
melanoma-specific lncRNA SAMMSON (25). Complexes directly 
bound to the endogenous NEAT1 transcript were purified from 
freshly isolated nuclei of MCF-7 (human breast adenocarcinoma) 
cells exposed to ultraviolet (UV) cross-linking, using tiling DNA-
based biotinylated oligonucleotides, targeting the 5′ portion of 
NEAT1 (N1_5′). In parallel, control probes (Ctrl) were designed 
against the melanoma-specific LINC00698 transcript, which is not 
expressed in MCF-7 cells (Fig. 1A). The quality of the nuclear isola-
tion was verified by reverse transcription quantitative polymerase 
chain reaction (RT-qPCR), assessing the cytoplasmic RNA encoding 
the 40S ribosomal protein S14, as well as NEAT1 and MALAT1, 
both of which are exclusively nuclear transcripts (Fig. 1B). The effi-
ciency and specificity of the N1_5′ pulldown was confirmed by 
RT-qPCR. Whereas a robust signal was detected for total NEAT1 
(NEAT1) and NEAT1_2 transcripts in the isolated RAP extracts, 
neither the housekeeping TBP and HPRT1 mRNAs nor the lncRNA 
MALAT1, used as negative controls, were detectable (Fig. 1C).
RAP experiments were performed in biological triplicates, and 
purified proteins were analyzed by label-free mass spectrometry 
(MS). Principal component analysis (PCA) of the replicates con-
firmed the clustering of the samples into two groups: the control 
(Ctrl) and the RAP pulldown performed with NEAT1-specific probes 
(N1_5′) (fig. S1A). We identified 34 proteins, which were signifi-
cantly enriched by the N1_5′ probes [t test, P < 0.05 and fold change 
(FC) > 1.6], as high-confidence NEAT1 interactors (table S1). Two 
of these were known PS proteins (Fig. 1D) (43). Gene ontology 
analysis using the Search Tool for Recurring Instances of Neighboring 
Genes (https://string-db.org) indicated that the remaining NEAT1 
interactors are mainly involved in key aspects of RNA biogenesis 
and processing (table S2). Among these were multiple subunits of 
the Integrator and mRNA 3′ end processing complexes, including 
INTS1, INTS3, INTS6, CSTF1, CSTF2, CSTF2T, CSTF3, CPSF1, 
WDR33, SYMPK, and FIP1L1 (Fig. 1E, top). One-third (11 of 34) 
of all high-confidence interactors belonged to these two multicom-
ponent protein complexes. Three additional previously unknown 
NEAT1 interactors were also identified, namely, the F-box protein 
FBXO11 and its binding partner CUL1, as well as the transcription 
factor TCF7L2 (Fig. 1E, bottom).
These findings were next validated by RAP Western blotting exper-
iments. Using the N1_5′ probes, the interactions between NEAT1 
and FBXO11, TCF7L2, CPSF2 (component of the mRNA 3′ end 
processing machinery), INTS3, INTS11 (catalytic subunit of Integrator 
complex), INIP (auxiliary component of the complex), H3 (used as 
negative control), and the PS proteins PSF, PSPC1, NONO, and 
TDP-43 (used as a positive control) were confirmed (Fig. 1F).
Integrator limits PS biogenesis by promoting NEAT1 
isoform switching
The identification of several components of the Integrator complex 
as high-confidence NEAT1 RNA interactors raises the possibility 
that the complex contributes to the regulation of NEAT1 isoform 
switching. To test this hypothesis, we first checked for interaction 
between NEAT1 transcript and INTS11, the catalytic subunit of 
Integrator. To this end, we performed enhanced cross-linking and 
immunoprecipitation (eCLIP), a well-established and comprehensive 
procedure for the identification of RNA binding protein targets (26), 
in HeLa cells using two distinct INTS11-specific antibodies (Fig. 2A). 
Quantification of the eCLIP signal (size-matched coverage) relative 
to the control immunoglobulin G (IgG) showed an enrichment of 
INTS11 binding to the NEAT1_1 transcript (Fig. 2B). RNU11 and 
other noncoding RNAs are shown as positive and negative controls, 
respectively. Note that the binding between integrator and NEAT1_1 
could also be validated in MCF-7 cells by RNA immunoprecipita-
tion (RIP) qPCR (Fig. 2C and fig. S1B). In agreement with previous 
findings (7, 27), eCLIP detects two major peaks at the 5′ end of the 
transcript that may be implicated in premature transcriptional ter-
mination. Another peak is detected immediately upstream of the 3′ 
end of NEAT1_1 (Fig. 2D).
To determine whether Integrator contributes to the 3′ end mat-
uration of NEAT1_1, we performed RNA sequencing (RNA-seq) in 
HeLa cells expressing a doxycycline-inducible short hairpin RNA 
(shRNA) construct targeting INTS11 or green fluorescent protein 
(GFP) as a control (shCtrl) (Fig. 2E). We observed an accumulation 
of the long NEAT1_2 isoform in the INTS11 knockdown (KD) cells 
(Figs. 2E and 3A and fig. S1C). In agreement with the total RNA-seq data, 
small RNA-seq (smRNA-seq) analysis, which captures cleavage 
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Fig. 1. NEAT1 interactome is enriched in 3′ end processing factors. (A) RAP–mass spectrometry (MS) strategy to study NEAT1 interactome. Probes targeting either the 
melanoma-specific LINC00698 (Ctrl) or the 5′ end of NEAT1 short and long isoforms (N1_5′) were used. (B) Relative abundance by RT-qPCR of the S14, NEAT1, and MALAT1 
in MCF-7 cytoplasmic and nuclear fractions. (C) Both form-specific (NEAT1) and long form-specific (NEAT1_2) RT-qPCR to evaluate the efficiency of the RAP. Three abun-
dant coding and noncoding transcripts (MALAT1, TBP, and HPRT1) are shown as negative controls. Error bars represent means ± SD. P values were calculated by two-way 
analysis of variance (ANOVA), using three biological replicates. ****P < 0.0001. (D) Venn diagram showing overlap between NEAT1 previously identified partners (orange) 
and candidates identified in this study (brown). In purple, the interactors considered for further analysis. (E) Volcano plots indicating the interactors significantly enriched 
(t test, P < 0.05 and FC > 1.6) by N1_5′ probes. Highlighted candidates are color-coded by protein complexes. The x axis indicates the ratio N1_5′/Ctrl in log2 scale. The y 
axis is the –log10 (t test, P value). (F) RAP Western blot validation of novel interactors. PS proteins PSF, PSPC1, NONO, and TDP-43 were used as positive controls, and H3 was 
used as negative control. Input (INP) was either 1 or 2% of the total nuclear lysate.
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products of INTS11 catalysis (RNA species smaller than 75 nt), in-
dicated a decrease in the small RNA cleavage product of NEAT1_1 
(Fig. 3A, bottom). Likewise, 3′ mRNA-seq, which detects selectively 
polyadenylated transcripts, confirmed a decrease in the NEAT1_1 
3′ ends upon Integrator KD (fig. S1D).
This phenotype was not an off-target effect, as it was rescued by 
concomitant expression of a wild-type (WT) form of INTS11 but not 
a catalytic dead mutant (E203Q) (Fig. 3B and fig. S1E), indicating 
that the NEAT1 isoform switching is dependent on INTS11 enzymatic 
activity. Similar results were obtained for the snRNA RNU11, a 
well-known Integrator target (fig. S1, F and G).
The phenotype was not cell type specific, as it could be recapitu-
lated in the breast cancer cell line MCF-7 in which INTS11 was 
silenced by small interfering RNA (siRNA) (Fig. 3C and fig. S1H). 
As expected, the levels of the 3′ end extended product of two 
well-established Integrator targets, RNU11 and RNU12, as indicated 
by the percentage of long transcript relative to the gene body (Fig. 3C). 
Together, these data further supported a direct contribution of 
Integrator in the regulation of NEAT1 isoform switching and indi-
cated that the catalytic activity of Integrator is required for the correct 
processing of the NEAT1 transcript.
The observed increase in NEAT1_2 levels upon silencing of 
INTS11 raised the possibility that Integrator activity limits the for-
mation of PS. Consistent with this possibility, an increase in the 
number and size of NEAT1_2 foci was observed by RNA fluorescence 
in situ hybridization (FISH) in MCF-7 cells depleted for INTS11 
(Fig. 3D). RNA FISH coupled to immunofluorescence (IF) revealed 
that the foci colocalized with the PS-specific protein PSPC1, thus 
demonstrating an increase in PS assembly in INTS11-depleted cells 
(Fig. 3E and fig. S1I). This observation indicated that Integrator re-
strains the formation of PS nuclear bodies by promoting NEAT1_1 ex-
pression, at the detriment of NEAT1_2, under steady-state conditions.
Stress does not disrupt NEAT1-Integrator interaction 
and promotes accumulation of Integrator at PS
Various forms of stress stimulate PS formation (28, 29). It was re-
cently shown that exposure of cells to hydroxyurea (HU), which in-
hibits deoxyribonucleotide synthesis and thus causes DNA replication 
stress, induces the formation of large PS (17). Accordingly, increased 
PS formation was detected by RNA FISH and RNA FISH combined 
to IF for PSPC1 in HU-exposed MCF-7 cells (Fig. 4A). The increase 
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Fig. 2. Integrator is a novel NEAT1 interactor. (A) eCLIP protocol (HeLa). IP, immunoprecipitation; INP, input. (B) Quantification of INTS11 (and size-matched IgG) eCLIP 
signal at indicated loci relative to expression levels (RNA-seq–based). (C) RIP RT-qPCR for INTS11 in MCF-7. Error bars represent means ± SD. P values were calculated by 
two-way ANOVA, using three biological replicates. **P < 0.01 and ****P < 0.0001. (D) INTS11 eCLIP at NEAT1 locus. Binding site on NEAT1 is in pink. In the insert, the 3′ end 
peak and corresponding position on NEAT1 transcript. (E) FISH for NEAT1 (both transcripts, red) and NEAT1_2 (long transcript, green) in HeLa upon INTS11 KD (shINTS11) or 
control (shCtrl).
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Fig. 3. Integrator restrains PS biogenesis. (A) RNA-seq (total and small) of HeLa shINTS11 or shCtrl at NEAT1 locus. The blue shade indicates NEAT1 termination site. 
Dox, doxycycline. (B) RNA-seq (total and small) of HeLa expressing INTS11 catalytic dead mutant (E203Q), empty vector (empty), or WT INTS11 at NEAT1 locus. (C) RT-qPCR for 
NEAT1 and NEAT1_2 expression (relative to siC) in MCF-7 upon siINTS11. RNU11 and RNU12 and their read-through are positive controls. Error bars represent means ± SD. 
P values were calculated by two-tailed t test, using three biological replicates. ***P < 0.001 and ****P < 0.0001. (D) FISH quantification for NEAT1 and NEAT1_2. Error bars 
represent means ± SD. P values were calculated by paired two-tailed t test. ****P < 0.0001. (E) Immunofluorescence (IF) for the PS protein PSPC1 (green) and RNA FISH for 
NEAT1 in MCF-7 cells siINTS11 (total NEAT1, red; NEAT1_2, magenta; nuclei, blue). Right: 3D quantification peaks represent signal intensities at colocalization site.
Barra et al., Sci. Adv. 2020; 6 : eaaz9072     3 July 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 16
of the NEAT1 locus (particularly NEAT1_2) as demonstrated by the 
fact that treatment with actinomycin D (RNA Pol II inhibitor) abol-
ished HU-induced NEAT1 up-regulation (Fig. 4B). We reasoned that 
stress-induced NEAT1_2 expression and PS formation may be caused, 
at least in part, by a decrease in the recruitment of Integrator to the 
NEAT1 transcript. To test this hypothesis, we performed RAP-MS 
experiments on freshly isolated nuclei of MCF-7 cells exposed to 
HU (fig. S2, A and B). As expected, the recovery of NEAT1_2 RNA 
in this assay was higher in HU-treated than in dimethyl sulfoxide 
(DMSO)–treated cells (fig. S2A). Unexpectedly, our RAP-MS data 
revealed that most of the previously enriched candidates from un-
stimulated cells were also recovered in stimulated cells (Fig. 4C, fig. 
S2C, and table S3). Integrator subunits and mRNA 3′ end processing 
factors were also efficiently pulled down by the RAP N1_5′ probes 
under these experimental conditions. These interactions were fur-
ther validated by RAP Western blotting analysis (Fig. 4D). IF for the 
PS protein PSPC1, in intact cells exposed to HU, was performed to 
confirm the colocalization of CPSF1 and CPSF2 (as well as FBXO11 
and TCF7L2) with PSPC1 (fig. S2D) and thus their recruitment to PS. 
Moreover, stochastic optical reconstruction microscopy (STORM) 
showed a significant colocalization of the Integrator subunit INTS1 
with the PS protein NONO in cells exposed to HU (Fig. 4E). Together, 
these data demonstrated that DNA damage–induced stress is not 
sufficient to disrupt the interaction between NEAT1 and Integrator. 
These experiments also showed that Integrator accumulates to PS 
nuclear bodies in DNA-damaged cells.
DNA damage–induced PS formation is, at least partly, a conse-
quence of activation of the p53 transcription factor (fig. S2B), which, 
in turn, enhances NEAT1 promoter activity (12, 22). Accordingly, 
exposure to the MDM2 antagonist Nutlin-3a, which causes stabili-
zation of p53 without inducing cellular stress responses, was sufficient 
to increase NEAT1_2 transcription and enlarged PS (Fig. 5, A and B). 
Consistently, similar to HU, exposure to Nutlin-3a did not disrupt 
NEAT1-Integrator association as demonstrated by RAP-MS (Fig. 5C, 
fig. S2E, and table S4). PCA of all the RAP-MS experiments under 
control and stressed conditions confirmed the consistency of these 
results (fig. S2F). RAP Western blotting (Fig. 5D), confocal micros-
copy, and super-resolution microscopy (Fig. 5E and fig. S2G) fur-
ther confirmed that activation of p53 by Nutlin-3a is not sufficient 
to disrupt the interaction between NEAT1 and Integrator and that 
Integrator accumulates to PS nuclear bodies under these experi-
mental conditions.
Note that exposure to HU or Nutlin-3a did not significantly alter 
the expression levels of various Integrator subunits (Fig. 6A). The 
processing of several well-known Integrator targets, including his-
tones (7), was severely compromised upon induction of DNA damage 
or p53 activation (Fig. 6, B and C). Further evidence of impaired 
Integrator activity was also obtained in MCF-7 treated with Nutlin-3a, 
with HU, or transfected with siINT11, using a reporter construct 
that directs expression of GFP upon read-through of RNU7 (fig. S3, 
A to C) (30). These data indicated that Integrator activity is com-
promised in cells exposed to stress, possibly as a consequence of its 
recruitment to PS. Together with the observation that stress does not 
disrupt the interaction between NEAT1 and Integrator, these data 
favor a model in which up-regulation of NEAT1_2 levels and PS 
formation in stressed cells (exhibiting elevated transcriptional rates of 
NEAT1) occurs because the amount of functional Integrator available 
to process NEAT1 transcripts becomes rate liming. Consistent with 
this model, overexpression of exogenous INTS11 (fig. S3D) abolished 
stress-induced up-regulation of NEAT1_2 (Fig. 6, D and E), decreased 
PS assembly (Fig. 6F), and phenocopied the decrease in p53 activa-
tion and increase in levels of DNA damage observed following 
NEAT1_2 KD (Fig. 6, G and H).
Low levels of Integrator components correlate with poorer 
survival and response to chemotherapy
We previously established a genetic link between PS formation and 
tumorigenesis and demonstrated that PS can be detected in about 
65% of the human carcinomas analyzed, including skin squamous 
cell carcinoma and ovarian carcinomas. We also showed that ex-
pression of NEAT1_2, but not NEAT1_1, reliably predicts the re-
sponse of ovarian cancer to platinum-based chemotherapy (12). 
Given that Integrator modulates NEAT1_2 expression and PS bio-
genesis, we therefore assessed whether correlations between (altered) 
expression of Integrator subunits and overall patient survival (OS) 
may exist. Analysis of patients that underwent chemotherapy in the 
ovarian cancer cohort (GSE30161) analyzed in our previous study 
(12) confirmed that lower levels of INTS10 and INTS11 significantly 
correlated with worse OS (Fig. 7A). In this cohort, the differential 
expression levels of INTS11 and INTS10 exhibit an inverse relation-
ship with that of NEAT1_2 as shown in Fig. 7B. Analysis was then 
expanded to publicly available TCGA datasets corresponding to 11 
epithelial cancer cohorts. In addition to gene expression levels, the 
results were adjusted for the effect of other risk factors (covariates) 
such as age, race, stage, and gender by performing a multivariate 
analysis using the Cox proportional hazards model (table S5). 
Moreover, within these studies, only participants who underwent 
treatment with various chemotherapeutic agents were retained. Con-
sistently, patients with lower levels of INTS6, INTS7, INTS8, INTS10, 
INTS11, and INTS12 exhibited poorer OS (Fig. 7C and fig. S4). 
Notably, the most striking effect was observed with the catalytic 
subunit of Integrator, INTS11. We subsequently performed a similar 
analysis using multiple Affymetrix gene expression cancer datasets, 
including two colorectal cancer cohorts (GSE33113 and GSE39582) 
and two breast cancer cohorts, one of which is split into two Gene 
Expression Omnibus (GEO) submissions (GSE9195, GSE6532.1, and 
GSE6532.2). Again, a significant correlation between low expression 
levels of Integrator subunits and a poorer OS was observed (table S5). 
Together, these data support a model in which decreased levels/
activity of the Integrator complex may affect chemotherapeutic re-
sponse via modulation of the biogenesis of NEAT1_2 and PS.
DISCUSSION
Using an unbiased proteomics screen, we have identified known and 
previously unknown NEAT1 RNA binding partners, such as the tran-
scription factor TCF7L2 and a member of the F-box protein family, 
FBXO11, which were both subsequently validated as bona fide NEAT1 
interactors and novel PS proteins. This study therefore provides a 
new list of factors that may modulate NEAT1 and PS biology. A large 
proportion of the identified NEAT1 interactors belongs to two function-
ally related protein complexes, namely, the core 3′ end processing 
and Integrator complexes. The Integrator complex contains two es-
sential Integrator subunits, INTS11 and INTS9, which are homologous 
of CPSF73 (alias CPSF3) and CPSF100 (alias CPSF1), respectively. 
Integrator interacts with the CTD of RNA Pol II and processes newly 
transcribed RNA molecules, mainly nonpolyadenylated transcripts 
and UsnRNAs. Integrator has also been recently implicated in the 
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Fig. 4. NEAT1 interactors do not dissociate upon DNA damage–induced PS formation. (A) Top: RNA FISH for total NEAT1 (red) NEAT1_2 (green) nucleus (blue). Bottom: 
RNA FISH combined to IF for total NEAT1 (red), NEAT1_2 (magenta), PSPC1 (green), and nucleus (blue) in MCF-7 exposed to HU. (B) RT-qPCR of total NEAT1 transcript (NEAT1) 
and long form (NEAT1_2), in MCF-7 exposed to HU after a pulse of actinomycin D (ActD). SRSF1 is a positive control, and 16S is a negative control. Error bars represent 
means ± SD. P values were calculated by two-way ANOVA, using three biological replicates. *P < 0.05, ***P < 0.001, and ****P < 0.0001. (C) RAP-MS experimental approach in 
MCF-7 treated with HU. In the volcano plots, significantly enriched protein candidates (t test, P < 0.05 and FC > 1.6) are color-coded by protein complexes. (D) RAP Western blot 
in MCF-7 for PS proteins (positive controls) and the newly identified NEAT1 interactors. H3 is a negative control. Input (INP) loaded is either 1 or 2% of the total nuclear lysate. 
(E) STORM images of the PS protein NONO (red) and INTS1 (green) in MCF-7 treated with HU. Voronoi diagram and quantification of NONO (class A) and INTS1 (class B) 
colocalization are shown.
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Fig. 5. NEAT1 interactome does not change upon oncogenic stress–induced PS formation. (A) Top: RNA FISH for total NEAT1 (red) NEAT1_2 (green) nucleus (blue). 
Bottom: RNA-FISH combined to IF for total NEAT1 (red), NEAT1_2 (magenta), PSPC1 (green), and nucleus (blue) in MCF-7 exposed to Nutlin-3a. (B) RT-qPCR of total NEAT1 
transcript (NEAT1) and long form (NEAT1_2), in MCF-7 exposed to Nutlin-3a after a pulse of actinomycin D. SRSF1 is a positive control, and 16S is a negative control. Error 
bars represent means ± SD. P values were calculated by two-way ANOVA, using three biological replicates. (C) Scheme of the RAP-MS approach in MCF-7 treated with 
Nutlin-3a. In the volcano plots, significantly enriched protein candidates (t test, P < 0.05 and FC > 1.6) are color-coded by protein complexes. (D) RAP Western blot per-
formed in MCF-7 exposed to Nutlin-3a. Western blot was probed with the PS proteins (positive controls) and the newly identified NEAT1 interactors. H3 is used as negative 
control. Input (INP) is either 1 or 2% of the total nuclear lysate. (E) STORM images of the PS protein NONO (red) and INTS1 (green) in MCF-7 cells treated with Nutlin-3a. 
Voronoi diagram and quantification of NONO (class A) and INTS1 (class B) colocalization are shown.
Barra et al., Sci. Adv. 2020; 6 : eaaz9072     3 July 2020
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Fig. 6. Stress compromises Integrator activity and determines read-through at target genes. (A) RT-qPCR (left) and Western blot (right) for integrator subunits (INTS) in 
MCF-7 exposed to Nutlin-3a and HU. RT-qPCR: error bars represent means ± SD; P values calculated by two-way ANOVA using three biological replicates were not significant 
(ns). Western blot: GAPDH and Laminin A + C are loading controls; p53, p21, and phospho-H2AX (p-H2AX) show efficacy of the treatment. (B and C) RT-qPCR of read-
through at known INTS11 targets in MCF-7 exposed to HU, Nutlin-3a, or siINTS11 (C). Ratios between read-through (unprocessed) and gene body are calculated on normal-
ized expression levels. Error bars represent means ± SD. P values were calculated by two-way ANOVA, using three biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001, 
and ****P < 0.0001. (D) RT-qPCR for total NEAT1 and NEAT1_2 in MCF-7 exposed to stress and overexpressing WT INTS11 (or empty vector). Normalized expression levels 
are relative to the control (DMSO). Error bars represent means ± SD. P values were calculated by two-way ANOVA, using three biological replicates. *P < 0.05, ***P < 
0.001, and ****P < 0.0001. (E) Western blot confirming INTS11 overexpression (OE). p53, p21, and phospho-H2AX detect p53 activity and DNA damage; vinculin is a 
loading control. (F) FISH staining and relative quantification (biological triplicate) of NEAT1 (both transcripts, red) and NEAT1_2 (long transcript, green) in MCF-7 with 
WT INTS11 OE and exposure to stress. Error bars represent means ± SD. P values were calculated by two-way ANOVA, using three biological replicates. *P < 0.05 and 
**P < 0.01. (G) RT-qPCR for NEAT1 and NEAT1_2 in MCF-7 transfected with siN1_2 and exposed to stress. Normalized expression levels are relative to the control (siC). Error 
bars represent means ± SD. P values were calculated by two-way ANOVA, using three biological replicates. **P < 0.01 and ***P < 0.001. (H) Western blot analysis for p53, 
p21, and phospho-H2AX, confirming the efficacy of the treatments; GAPDH is a loading control.
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Fig. 7. Low levels of Integrator components correlate with poorer survival and response to chemotherapy. (A) Kaplan-Meier (KM) survival plots of patients from the 
ovarian cancer Affymetrix cohort (OVC; GSE30161). Patients treated with chemotherapy were selected and stratified on the basis of the expression levels of INTS11 and 
INTS10. The KM log rank test P values indicate the difference in overall survival between the patients with significantly low (and high) expression levels of Integrator 
subunit. (B) Bar plots represent the log FCs of INTS10 and INTS11 and the corresponding FCs for NEAT1_2 among respective samples. FCs were calculated using z scores to 
represent the classic null hypothesis of no overall FC in the mean of all samples. (C) KM survival curve of patients treated with chemotherapy from 11 epithelial cancer 
cohorts combined (TCGA database). Patients were stratified in three groups based on the expression levels of Integrator subunits (blue, low; black, intermediate; red, high). 
Graphs refer to the subunits INTS11 and INTS10, whose lower expression levels significantly correlate with worse prognosis of chemo-treated patients. We also indicate 
the P value of the Cox analysis and the hazard ratio (HR) calculated for INTS11. (D) Proposed model.
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modulation of gene expression via regulation of protein-coding gene 
transcription initiation and premature termination (7, 27), in RNA 
Pol II pause release (31, 32), and in the biogenesis of enhancer RNAs 
(6). Here, we provide functional evidence for an unexpected role of 
Integrator in the regulation of the isoform switching of the lncRNA 
NEAT1. Our data are compatible with a model in which Integrator 
is recruited to the NEAT1 transcript and participates in the cleavage 
and subsequent processing of the polyadenylated NEAT1_1 isoform 
(Fig. 7D). Although eCLIP data indicate that Integrator is also re-
cruited to the 5′ end of the NEAT1 transcript, our data highlight a 
role for Integrator in the processing of the 3′ end of NEAT1_1 to 
restrain the expression of the long isoform and, thereby, PS forma-
tion. Moreover, our previous observation that NEAT1_1 is constantly 
made and degraded by the exosome (17) raises the possibility that 
processing of this 3′ end site by Integrator is a critical step in this 
degradation process. Previous data have already implicated the 3′ end 
CFIm complex in the processing of NEAT1_1. Whether Integrator 
and the core 3′ end processing machinery cooperate to process 
polyadenylated transcripts such as NEAT1_1 or work independently 
on different pools of transcripts remains to be addressed.
The interaction between NEAT1 and Integrator is not disrupted 
in cells exposed to stress (i.e., HU-induced replication stress) or in 
cells in which we artificially increased the transcription rate of 
NEAT1 (i.e., upon Nutlin-3a exposure). These data therefore favor 
a model in which bypassing NEAT1 cleavage may occur because the 
pool of Integrator available is not sufficient to process the high 
amounts of NEAT1 transcripts being produced in cells exposed to 
stress (or in which the transcriptional rate of NEAT1 is artificially 
elevated). The ratio between the rate of NEAT1 transcription and 
overall expression levels of the Integrator complex may therefore 
determine whether NEAT1_2 remains expressed and whether PS are 
being assembled (Fig. 7D). This model is further supported by the 
fact that NEAT1 is an unusually abundant lncRNA (the “A” in NEAT1 
refers to “abundant”), being expressed at levels that rival highly ex-
pressed housekeeping genes, such as GAPDH.
The observation that the NEAT1-Integrator association is not 
disrupted in stressed cells may have important functional implica-
tions. We showed that several components of Integrator colocalize 
with PS in stressed cells. PS assembly is thought to phase separate its 
content from the nucleoplasm (19, 28), and thus Integrator recruit-
ment to PS may affect its recruitment and activity at other loci. 
Paralleling this possibility, a comparable cross-regulation between 
TDP-43 and NEAT1/PS was recently shown to promote pluripotency- 
differentiation transition (15). In addition to repressing the forma-
tion of PS by enhancing the maturation of NEAT1_1, TDP-43 also 
regulates alternative 3′ end processing of transcripts encoding plu-
ripotency factors, such as SOX2. PS sequester TDP-43, just like 
Integrator, and thereby reduce its binding to polyadenylated RNAs 
to promote exit from pluripotency (15). In a similar way, sequestra-
tion of Integrator to PS may contribute to an overall decrease in the 
processing of small and/or enhancer RNAs in stressed cells and 
thereby cause an overall down-regulation of gene expression and/or 
rewiring toward a “stress” transcriptome that helps cells cope with 
(chemotherapy-induced) stress. In support of this hypothesis, our 
data show that the processing of two well-known Integrator targets 
RNU11 and RNU12 is compromised in cells exposed to HU and 
Nutlin-3a (Fig. 6B). Similarly, the 3′ end processing of the replication- 
dependent histones, previously shown to be affected by silencing of 
INTS3 (7), was also compromised under these experimental condi-
tions (Fig. 6C). On the other hand, overexpression of INTS11 under 
condition of stress abolished the increase in NEAT1_2 and PS and 
increased DNA damage, thus phenocopying the effects observed 
upon NEAT1_2 KD (Fig. 6, G and H). This model is compatible with 
the switch from cell cycle arrest/dormancy to apoptotic cell death we 
observed in cancer cells exposed to chemotherapy following NEAT1_2 
silencing (and PS disruption) and suggests a role for PS as key mod-
ulators of 3′ end RNA processing.
Last, our data also establish an important mechanistic link be-
tween Integrator and PS biology. Given the recently recognized role 
of PS as modulators of cancer development and sensitivity to cancer 
therapy, our work therefore highlights the importance of studying 
Integrator in a cancer biology context. In keeping, we provide evi-
dence that decreased expression of various components of the Inte-
grator complex, as well as, in particular, its catalytic subunit INTS11, 
correlates with poorer clinical outcome for patients exposed to 
chemotherapy. These observations may ultimately bear important 
therapeutic implications. Agents that may increase either the half-life 
or the recruitment of Integrator to the NEAT1 locus, or stimulate 
INTS11 catalytic activity, would be expected to impair PS formation 
and thereby increase chemosensitivity.
MATERIALS AND METHODS
Cell culture and cloning
All cell lines were acquired from the American Type Culture Col-
lection Cell Biology collection and kept in culture at 37°C and 5% 
CO2 in medium supplemented with 1% penicillin and streptomycin 
(Invitrogen) and 10% fetal bovine serum (Invitrogen). All cell lines 
tested negative for mycoplasma contamination. MCF-7 breast cancer 
cell line was grown in RPMI 1640 GlutaMAX (Gibco, Invitrogen) 
supplemented with insulin (10 g/ml; Sigma-Aldrich, I9278).
INTS11- and GFP-inducible KD clones (HeLa cells) were estab-
lished as previously described in (6). HeLa rescue cells were established 
by cloning the same shINTS11 sequence into Tet-pLKO-neo vector 
(Addgene), and single clones were selected with G418 (500 g/ml). 
shRNA-resistant N-terminal Flag-tagged WT or E203Q mutant INTS11 
complementary DNA (cDNA) (5) was cloned into Cumate-pLenti-
Cloning-2A-GFP vector (ABM Inc.) and transfected into a shINTS11- 
Tet-pLKO-neo single clone. Stable cell lines were maintained in 
puromycin (2 g/ml) and G418 (200 g/ml) containing Dulbecco’s 
modified Eagle’s medium. KDs were induced by adding of doxycycline 
(1 g/ml) into the culture medium daily for 3 days. WT INTS11 cDNA 
was cloned into a VP16 plasmid (Addgene) to transiently overexpress 
(OE) INTS11 in MCF-7 cells to perform rescue experiments.
Cell transfections
For transient KD experiments, MCF-7 cells were seeded in six-well 
plates (200,000 cells per well) and transfected with Lipofectamine 
RNAiMax (Thermo Fisher Scientific) according to the manufacturer’s 
instructions, using 30 nM siNEAT1 or siNEAT1_2 siPOOLs (siTOOLS 
Biotech) or 35 nM ON TARGETplus siCPSF3L (siINTS11, Dharmacon). 
Transient transfections with the plasmid of interest were performed 
in six-well plates (120,000 cells per well) using Lipofectamine 2000 
(Thermo Fisher Scientific) according to the manufacturer’s instruc-
tions. We transfected either 10 g of DNA for the pVP16-INTS11 
overexpression construct or 60 g of DNA for the U7-GFP reporter 
construct (30). Cell medium was refreshed after 8 hours from trans-
fection, and treatments started 24 hours after transfection.
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Cell treatments
MCF-7 cells were treated with 5 M Nutlin-3a (Selleckchem) for 
24 hours or with 1 mM HU (Sigma-Aldrich) for 44 hours. For 
actinomycin D experiments in Figs. 4B and 5B, MCF-7 cells were 
seeded in six-well plates (180,000 cells per well) and exposed to 
1-hour pulse of 3 M actinomycin D (Sigma-Aldrich) 24 hours after 
seeding. After two washes in phosphate-buffered saline (PBS), cells 
were treated with either DMSO (vehicle), 5 M Nutlin-3a, or 1 mM 
HU for 24 hours. RNA was extracted with TRIzol lysis reagent 
(QIAGEN) according to the manufacturer’s instructions, and deoxy-
ribonuclease (DNAse) treated to measure the transcript levels of the 
16S ribosomal RNA, the lncRNA NEAT1 (NEAT1) and its long form 
specifically (NEAT1_2), and SRSF1 (used here as positive control) 
by RT-qPCR.
In the rescue experiments, cells were first transfected with either 
INTS11-overexpressing construct or with siNEAT1_2 siPooLs and 
then continuously treated with DMSO, Nutlin-3a (5 M), or HU 
(1 mM) for 24 hours (rescue with siNEAT1_2) or 72 hours (rescue 
with INTS11 OE plasmid). For the RNA read-through experiments 
of Fig. 6 (B and C), MCF-7 cells were either transfected with 35 nM 
ON TARGETplus against CPSF3L (siINTS11) or exposed to stress 
for 108 hours (5 M Nutlin-3a or 1 mM HU).
Cell fractionation
Nuclear and cytoplasmic extracts were prepared from 15-cm plates 
using the Nuclei EZ prep kit (Sigma-Aldrich) according to the 
manufacturer’s instructions. The quality of the nuclear isolation was 
verified by RT-qPCR, assessing the cytoplasmic RNA encoding the 
40S ribosomal protein S14 and the exclusively nuclear noncoding 
RNAs NEAT1 and MALAT1.
RAP and quantitative label-free MS
Briefly, for antisense purification of the protein interactors of NEAT1, 
100 g of Streptavidin Sepharose High Performance beads (GE 
Healthcare) were coupled overnight at 4°C to 800 pmol of biotinylated 
RAP probes against the 5′ portion of the NEAT1 transcript (N1_5′; 
Biosearch Technologies) or RAP probes designed against the 
melanoma-specific LINC00698 (Ctrl; Biosearch Technologies). MCF-7 
breast cancer cells (1.5 × 107 cells per treatment) were washed twice 
in PBS and UV cross-linked dry at 400 mJ/cm2 with a CL-1000 
Crosslinker (254-nm lamp). After performing cell fractionation as 
indicated above, nuclei were lysed in pulldown buffer [20 mM tris-HCl 
(pH 8.0), 200 mM NaCl, 2.5 mM MgCl2, and 0.05% Triton X-100 in 
diethyl pyrocarbonate (DEPC) water] supplemented with a cocktail 
of protease inhibitors [Halt Protease and Phosphatase Inhibitor 
Single-Use Cocktail (100×), Thermo Fisher Scientific], 1 mM 
dithiothreitol, and SUPERase• In RNase (ribonuclease) Inhibitor 
(60 U/ml; Life Technologies). Lysates were incubated with the beads 
coupled to the RAP probes at 4°C for 3 hours. Beads were rinsed 
three times with pulldown buffer and twice with DEPC-treated water. 
For MS analysis, proteins were rinsed in trypsin digestion buffer 
[20 mM tris-HCl (pH 8.0) and 2 mM CaCl2] and eluted by on-beads 
digestion with 1 g of trypsin (Promega) overnight at 37°C. Peptides 
were purified with OMIX Tips (C18 resin) and dried to be stored till 
MS analysis (see “Liquid chromatography–MS/MS analysis” section). 
For Western blot, proteins were directly eluted in 30 l of Laemmli 
buffer supplemented with tris(2-carboxyethyl)phosphine (TCEP), 
boiled for 15 min at 95°C, and stored at −80°C. For RNA elution, 
samples were first decross-linked at 56°C in decross-linking buffer 
[100 mM tris-HCl (pH 7.5), 50 mM NaCl, 10 mM EDTA, and 0.5% 
SDS] with proteinase K (Roche) to a final working concentration of 
2 mg/ml for 30 to 40 min and then extracted in TRIzol-chloroform 
and precipitated overnight at −80°C in 1/10th (v/v) NaCl and 100% 
EtOH. The purified RNA was treated with DNAse, measured with a 
nanodrop, and stored at −80°C.
Liquid chromatography−MS/MS analysis
The cleaned peptide mixtures were dried completely and resuspended 
in 20 l of loading solvent [0.1% trifluoroacetic acid in water/acetonitrile, 
2/98 (v/v)]. Two microliters of the peptide mixtures were analyzed by 
liquid chromatography (LC)–MS/MS on an UltiMate 3000 RSLCnano 
LC (Thermo Fisher Scientific, Bremen, Germany) in-line connected to 
a Q Exactive mass spectrometer (Thermo Fisher Scientific). Peptides 
were separated with a linear gradient at 300 nl/min from 98% solvent 
A (0.1% formic acid in water) to 55% solvent B [0.1% formic acid in 
water/acetonitrile, 20/80 (v/v)] in 120 min before ultimately reaching 
99% solvent B. The mass spectrometer was operated in data-dependent, 
positive ionization mode, automatically switching between MS 
and MS/MS acquisition for the 10 most abundant peaks in a given 
MS spectrum.
Proteomics data analysis
Data analysis was performed with MaxQuant (version 1.5.4.1) using 
the Andromeda search engine with default search settings including 
a false discovery rate (FDR) set at 1% on both the peptide and pro-
tein level. Spectra were searched against human proteins in the 
UniProt/Swiss-Prot database (database release version of August 2016 
containing 20,210 human protein sequences; www.uniprot.org). The 
mass tolerance for precursor and fragment ions was set to 20 and 
4.5 parts per million, respectively, during the main search. Enzyme 
specificity was set to C terminus to arginine and lysine, also allowing 
cleavage at arginine/lysine-proline bonds with a maximum of two 
missed cleavages. Variable modifications were set to oxidation of 
methionine (to sulfoxides) and acetylation of protein N termini. A 
minimum of one peptide was required for protein identification. 
We allowed for matching between runs using a 1-min match time 
window and a 20-min alignment time window. Proteins were quanti-
fied by the MaxLFQ algorithm integrated in the MaxQuant software. 
A minimum ratio count of two unique or razor peptides was required 
for quantification.
Further data analysis was performed with the Perseus software 
(version 1.5.5.3) loading the protein groups file from MaxQuant. 
First, proteins only identified by site, reverse database hits, and 
potential contaminants were removed. The label-free quantification 
(LFQ) intensities were log2 transformed, the replicate samples were 
grouped, and protein groups with less than three valid values in at 
least one group were removed. Missing values were then imputed 
with values from the lower part of the normal distribution repre-
senting the detection limit, leading to a list of 1063 reliably quanti-
fied proteins. Moreover, we filtered out proteins identified by 
less than three peptides (n = 995). Then, a t test was performed 
(FDR = 0.05) to compare the RAP N1_5′ with the RAP Ctrl samples 
and generate the volcano plots depicted in Figs. 1E, 4C, and 5C 
and figs. S2 (C and E). Of the 995 quantified protein candidates, 
698 candidates were enriched by N1_5′ RAP probes. Significantly 
enriched proteins (P < 0.05) with a N1_5′/Ctrl FC of >1.6 (arbitrary 
cutoff) were considered as highly confident NEAT1 interaction 
partners (tables S1, S3, and S4).
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Principal component analysis
Ellipses represent 95% confidence intervals, around each cluster’s 
centroid, calculated using Hotelling’s T 2 statistics. The axes are the 
respective first and second principal components with the percent 
variance captured by each principal component in the parentheses. 
The figure was generated in R using the “factoextra” package. The 
MS proteomics data have been deposited to the ProteomeXchange 
Consortium via the Proteomics Identification Data (PRIDE) partner 
repository with the dataset identifier PXD015158.
RNA immunoprecipitation
RIP was performed on freshly isolated nuclei from MCF-7 cells (2.5 
107 cells per sample) after UV cross-linking with UV254nm (0.4 J/cm2). 
Nuclei were lysed with polysome buffer [20 mM tris-HCl (pH 8.0), 
200 mM NaCl, 2.5 mM MgCl2, and 1% Triton X-100 in DEPC water] 
supplemented with a cocktail of protease inhibitors [Halt Protease 
and Phosphatase Inhibitor Single-Use Cocktail (100×), Thermo Fisher 
Scientific], 1 mM dithiothreitol, and SUPERase• In RNase Inhibitor 
(60 U/ml; Life Technologies) and precleared with protein A beads 
for 1 hour at 4°C. RIP was performed overnight at 4°C on a rotating 
wheel using 5 g of the specific antibody INTS11 (Sigma-Aldrich, 
A107128) or normal rabbit IgG (Millipore, 12-370) used as control. 
On the following day, 50 l of protein A Dynabeads (Invitrogen) 
were coupled to the antibody for 3 hours at 4°C. The beads were 
rinsed five times with polysome buffer and split in two to either elute 
proteins or RNA (see RAP protocol for elution steps).
Reverse transcription quantitative polymerase  
chain reaction
Total RNA was extracted with TRIzol lysis reagent (QIAGEN) ac-
cording to the manufacturer’s instructions. To improve the extract-
ability of NEAT1_2, we routinely perform the following additional 
step: TRIzol samples are heated at 56°C for 5 minutes or syringed 
20 times with 22-gauge insulin syringes (BD). RNA is DNAse-treated, 
and reverse-transcribed using the High-Capacity cDNA RT Kit 
(Thermo Fisher Scientific). RNA expression levels were measured by 
qPCR on a LightCycler 480 (Roche). Data were analyzed in qbase + 3.0 
(Biogazelle) using HPRT1, TBP, and GAPDH as reference genes. For 
the sequences of the RT-qPCR primers (see table S6). Primers for 
HIST transcripts (Fig. 6C) were taken from (7).
RAP (and RIP) analysis
The RAP (and RIP) efficiency was estimated by RT-qPCR starting 
from 0.2 g of RNA per sample. The enrichment of the gene of in-
terest for the RAP (RIP) experiment (NEAT1 and NEAT1_2 primers) 
was calculated applying the ∆(∆Ct) method. Briefly, the Ct value of 
the RAP (RIP) elution was subtracted from the Ct value of the input 
for every gene, thus obtaining the ∆Ct for each gene in the RAP (RIP) 
sample. From the RAP (RIP), ∆Ct was subtracted by the ∆Ct of 
the RAP control (Ctrl probes, targeting the melanoma-specific 
LINC00698) or of the normal IgG (RIP), for every gene, thus ob-
taining the ∆(∆Ct). The equation “fold enrichment = 2 − (Ct)” was 
used to calculate the FC for each gene and was plotted as such.
Immunoblotting
Cells were scraped on ice in radioimmunoprecipitation assay buffer 
(RIPA) containing protease and phosphatase inhibitor cocktails 
(Thermo Fisher Scientific). The cell lysates were syringe five times 
with a 22-gauge needle, vortexed, incubated on ice for 10 min, and 
then centrifuged at 21,000g for 15 min at 4°C. Thirty or 20 g of 
total protein lysate were loaded on NuPAGE Novex 4 to 12% Bis-
Tris Protein Gels (Invitrogen) and probed with primary antibodies at 
4°C overnight (see the “Antibodies” section below).
eCLIP assay
eCLIP was performed in HeLa cells in duplicates as previously 
described in (26). Briefly, 2 × 107 cells were cross-linked by UV-C 
irradiation (254 nm, 400 mJ/cm2) and lysed on ice, followed by 
sonication. Antibodies (INTS11: Abcam ab75276 or Sigma Prestige 
HPA029025) were incubated with Dynabeads M-280 Sheep Anti- 
Rabbit IgG (Invitrogen, 11204D) for 1 hour. After limiting RNase I 
(Ambion) digest in presence of DNase, the lysate was subjected to 
immunoprecipitation at 4°C for 16 hours. In the following, 2% of 
the lysate was removed for size-matched input control. Immuno-
precipitation efficiency and specificity were verified by immunoblot 
using 20% of the immunoprecipitation material. Coimmunoprecip-
itated RNA was dephosphorylated, followed by 3′ RNA adapter li-
gation using T4 RNA Ligase (New England Biolabs). Input and IgG 
controls and INTS11-RNA complexes were run on a NuPAGE 4 to 
12% Bis-Tris Gel, transferred to nitrocellulose, and cut from the 
membrane between 65 and 145 kDa. Protein-bound RNA was re-
leased from the membrane by urea/proteinase K digest, followed by 
acid phenol/chloroform/isoamyl alcohol RNA extraction and puri-
fication using RNA Clean & Concentrator (Zymo Research). After 
RT (AffinityScript Reverse Transcriptase, Agilent), RNA was treated 
with exonuclease (ExoSAP-IT, Affymetrix) and removed by com-
bined NaOH/HCl treatment. A 3′ linker was ligated to the cDNA, 
and the resulting library was PCR-amplified using Q5 Polymerase 
(New England Biolabs), purified, and size-selected for sequencing. 
Single-end (SE100) sequencing was performed to an average of 
40 million reads per sample using Illumina HiSeq 3000 sequencer. 
Data were processed according to (26), including removal of repeti-
tive sequences before mapping against the human genome version 
hg19. eCLIP sequencing coverage of noncoding RNAs (MALAT1, 
RN7SL, TUG1, CRNDE, RNU11, NEAT1_1, and NEAT1_2 only) was 
quantified using bigWigAverageOverBed (33). Mean eCLIP signal 
per transcript was normalized to the expression levels of the lncRNA 
based on total RNA-seq (with the NEAT1_2 transcript arbitrarily set 
to 1). RNU11 was used as positive control, and highly expressed RN7SL 
(3000-fold higher expressed than NEAT1_2), moderately expressed 
MALAT1 (35-fold higher expressed than NEAT1_2), and lowly ex-
pressed TUG1 (0.5-fold) and CRNDE (0.1-fold) are also shown. Sig-
nificant INTS11 binding compared to input was determined using 
the CLIPper tool with a threshold of log2 of >3.7 and P < 10−26 (34).
RNA sequencing
A total of ~3 × 107 cells were used for total RNA extraction using 
TRIzol reagent (Thermo Fisher Scientific, #15596026) according 
to the manufacturer’s instructions. Genomic DNA was removed by 
Turbo DNAse treatment (Invitrogen, #AM1907). Total RNA-seq 
libraries were produced using TruSeq Stranded Total RNA library 
prep kit (Illumina, #20020596) with 500 ng of DNAse-treated input 
RNA. Genome-wide experiments were performed as two indepen-
dent biological replicates. To avoid a batch effect in library preparation 
and sequencing flow cell, these replicates were processed together. 
Raw fastq RNA-seq data were processed with Trimmomatic v0.32 
(35) and aligned to the human genome (hg19 version) using STAR 
aligner v2.5.3a (36) with default parameters. For visualization on the 
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University of California, Santa Cruz (UCSC) Genome Browser, all 
tracks were CPM (counts per million) normalized against the total 
number of usable reads in that data set using deepTools2 (37).
Small RNA analysis
A total of ~3 × 108 cells were used for nuclear fractionation, and 
RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, 
#15596026) according to the manufacturer’s instructions. Genomic 
DNA was removed by Turbo DNAse treatment (Invitrogen, #AM1907). 
Small RNA libraries were prepared using the SMARTer smRNA-seq 
Kit (Takara, #635030) with 750 ng of nuclear-enriched total RNA, 
and the experiments were performed as two independent biological 
replicates. Raw fastq reads were then adapter-trimmed (AAAAAAA) 
as recommend by SMARTer smRNA-seq kit (Takara, #635030) 
protocol using Cutadapt (v1.14), and reads less than 17 base pairs 
(bp) were discarded. First, we aligned the reads against human ele-
ments in Repbase (v23.08) with STAR (v2.5.3a) (36), repeat-mapping 
reads were removed, all others were then mapped against the full 
human genome (hg19 version), and we keep all unique aligned reads. 
For visualization on the UCSC Genome Browser, all tracks were 
CPM normalized against the total number of usable reads in that 
data set using deepTools2 (37).
3′ end RNA- seq (3′ quant-seq) and data analysis
Total RNA was extracted and treated with TURBO DNase for 
60 min at 37°C. We used QuantSeq 3′ mRNA-Seq Library Prep Kit 
REV (Lexogen) to prepare 3′ end libraries. 3′ Quant-seq was per-
formed on NEXTSeq 500 machine with single-end 75-bp sequenc-
ing. For the data analysis, we followed the Lexogen protocol. Briefly, 
raw fastq data were processed with BBMap (https://sourceforge.
net/projects/bbmap/) to remove the adapter contamination, poly(A) 
read-through and low-quality tails, and aligned to the human ge-
nome (hg19 version) using STAR aligner v2.5.3a (36) with the follow-
ing parameters (– outFilterType BySJout – outFilterMultimapNmax 
20 –alignSJoverhangMin 8 – alignSJDBoverhangMin 1 – outFilter-
MismatchNmax 999 –outFilterMismatchNoverLmax 0.1 – align-
IntronMin 20 – alignIntronMax 1000000 –alignMatesGapMax 
1000000 – outSAMattributes NH HI NM MD). For visualization on 
the UCSC Genome Browser, all tracks were CPM normalized against 
the total number of usable reads in that dataset using deepTools2 (37).
RNA FISH
RNA FISH was performed using Stellaris FISH probes (Biosearch 
Technologies) for human NEAT1: SMF-2036-1 for NEAT1_5 and 
VSMF-2251-5 for NEAT1_m. FISH was performed according to the 
manufacturer’s protocol. Briefly, cells were grown on slides (round 
cover glasses; VWR), fixed in 4% paraformaldehyde (PFA), and 
permeabilized in 70% EtOH over night at 4°C. Cells can be stained 
within the following 2 weeks maximum. Cells were washed twice in 
PBS and incubated for 5 min in FISH washing buffer [2× standard 
saline citrate (SSC) and 10% formamide]. Hybridization of FISH 
probes was carried out overnight at 37°C in 2× SSC, 10% formamide, 
and 10% dextran, in a dark humid chamber. After three washes with 
FISH washing buffer, slides were mounted in ProLong Gold Antifade 
containing 4′,6-diamidino-2-phenylindole (DAPI) (Thermo Fisher 
Scientific) and images acquired on a confocal microscope Nikon C2. 
Imaging panels were prepared using Imaris 7.2.3 and ImageJ [plugins 
such as Interactive three-dimensional (3D) surface plot and JACoP 
(Just Another Colocalization Plugin) were used, respectively, to 
produce the 3D plots to show colocalization and to quantify fluo-
resce and signal colocalization]. In Fig. 2I, 25 MCF-7 cells randomly 
selected cells from three biological replicates were used for 
the quantification.
Immunofluorescence
Cells were grown on slides, fixed in 4% formaldehyde, and permea-
bilized in 70% EtOH overnight at 4°C. Cells were washed twice in 
PBS and blocked for 1 hour in 3% bovine serum albumin (BSA) 
(Sigma-Aldrich), 10% goat serum (DAKO), and 0.2% Triton X-100 
(Sigma-Aldrich). Slides were incubated with primary antibodies at 
room temperature for 1 hour, washed three times in PBS, and incu-
bated with secondary antibodies, either anti-rabbit or anti-mouse 
Alexa Fluor 488 or Alexa Fluor 555 (Life Technologies) at room tem-
perature for 45 min. After three washes in PBS, slides were mounted 
in ProLong Gold Antifade Mountant with DAPI (Thermo Fisher 
Scientific). Images were acquired on a confocal microscope Nikon 
C2. Imaging panels were prepared using Imaris 7.2.3 and ImageJ.
IF combined to RNA FISH
Cells were grown on slides and fixed in 4% paraformaldehyde (PFA), 
permeabilized in 70% EtOH overnight at 4°C, and stained within 
the following 2 weeks maximum. The protocol for RNA FISH was 
performed first by incubation overnight at 37°C with FISH probes 
(NEAT1_5 Quasar 560 and NEAT1_m Quasar 670). The following 
day cells were incubated 30 min in FISH wash buffer at 37°C, washed 
twice in PBS, and fixed again at room temperature for 15 min in 2% 
PFA. After two washes in PBS, cells were blocked for 1 hour in IF 
buffer: 3% BSA (Sigma-Aldrich), 10% goat serum (DAKO), 0.2% 
Triton X-100 (Sigma-Aldrich), and SUPERase• In RNase Inhibitor 
(60 U/ml; Life Technologies), used also for further washes and anti-
body incubations. Slides were incubated with the primary antibody 
for 1 hour at room temperature in the dark. After three washes, cells 
were incubated for 45 min in secondary antibody anti-mouse or 
anti-rabbit Alexa Fluor 488 (Life Technologies) and washed again in 
PBS prior of mounting the slides with ProLong Gold Antifade Mountant 
with DAPI (Thermo Fisher Scientific). Images were acquired on a 
confocal microscope Nikon C2. Imaging panels were prepared using 
Imaris software 7.2.3 and ImageJ (the plugin Interactive 3D surface 
plot was used to produce the 3D plots to show colocalization; JACoP 
was used to quantify fluoresce and signal colocalization).
Antibodies
Western blotting experiments and/or IF and IF combined to FISH 
were performed using the following primary antibodies: PSPC1 
(Sigma-Aldrich, SAB4200503), PSF (Sigma-Aldrich, P2860), FBXO11 
(Novus Biologicals, NB100-59826), TCF7L2 (Cell Signaling Tech-
nology, 2565), CPSF1 (Santa Cruz Biotechnology, sc-166281), CPSF2 
(Santa Cruz Biotechnology, sc-165983), GAPDH (Abcam, ab9485), 
NONO (Bethyl Laboratories, A300-587A), TDP-43 (ProteinTech, 
12892-1 ap), CPSF3L or INTS11 (Sigma-Aldrich, A107128), INTS1 
(Millipore), INIP [C9orf80 (E-12), Santa Cruz Biotechnology, 
SC-137357], INTS3 (Bethyl Laboratories, A300-427A), INTS6 
(Bethyl Laboratories, A301-658A), INTS8 (Bethyl Laboratories, 
A300-269A), p53-DOI (Santa Cruz Biotechnology, sc-126), p21 
(Santa Cruz Biotechnology, sc-6246), phospho-H2AX (Cell Sig-
naling Technology, 2577), Laminin A + C (Abcam, ab108922), 
vinculin (Sigma-Aldrich, V9131), GFP (Clontech, 632375), and H3 
(Abcam, ab1791).
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Stochastic optical reconstruction microscopy
Cells were seeded in ibidi -Slide 4 wells and, after the indicated 
treatments, fixed in 4% formaldehyde for 10 min at room tempera-
ture. Cells were permeabilized in 0.5% Triton X-100 for 15 min and 
incubated overnight at −20°C with the primary antibody (recombi-
nant anti-nmt55/p54nrb antibody, Abcam, ab133574) at a dilution 
of 1:1500 and with INTS1 antibody (MilliporeSigma, MABS1984) at 
a dilution of 1:100. Last, samples were incubated for 30 min at room 
temperature with the secondary antibodies diluted 1:500, JF646 
anti-rabbit (Novus Biologicals, NB7156JF646) and Alexa Fluor 568 
anti-mouse (Thermo Fisher Scientific, A-11004).
Imaging experiments were carried out with a Nikon eclipse Ti2 
microscope equipped with Nikon Instruments (N-STORM). For 
two color dSTORM imaging, Janelia 646, and Alexa Fluor 568 sec-
ondary antibodies were used with MEA STORM imaging buffer 
and were imaged continuously with 5000 frames collected per filter 
range at a frequency of 20 ms. Images were acquired using a 100×, 
1.49–numerical aperture objective, and imaged onto a Hamamatsu 
C11440 ORCA-flash 4.0 camera. Storm localization analysis was 
carried out with ImageJ, thunderstorm plugin (1.3-2014-11-08). 
Molecule list files were then exported from ImageJ to be further 
analyzed using Coloc-Tesseler. Cluster analysis, specifically Voronoi 
function, was carried out after manually selecting regions of interest 
(ROIs). For quantification, the whole image was compared versus 
the selected ROI (1.5 m by 1.5 m) area of PS (high NONO signal) 
for all the treatment groups (at least 13 samples per group, we used 
16 for HU). A two-tailed t test was performed using GraphPad 
Prism 5. More details on the analysis method have been published 
previously (38, 39).
In silico survival analysis
Gene expression data and the corresponding clinical information 
from 11 cancers were downloaded from TCGA repository using the 
GDCquery function of the TCGAbiolinks R package (40). These data 
were breast cancer, lung adenocarcinoma, colon adenocarcinoma, 
glioblastoma, low-grade glioma, liver hepatocellular carcinoma, kidney 
renal cell carcinoma, adrenocortical carcinoma, skin cutaneous 
melanoma, and ovarian cancer. All the expression and clinical data 
were then merged and analyzed together excluding genes whose 
expression level was zero (0) in 50% of the samples. The data were 
subsequently normalized using the voom normalization (41) and 
partitioned the data into “normal” and “tumor” samples based on 
the information provided with the clinical data.
Differential expression was calculated on the basis of z scores, cal-
culated on the basis of the difference between the means of the normal 
samples and those from tumor samples correcting for sample hetero-
geneity using the SD across all genes. With this approach, we assigned 
differential expression to correspond to genes whose z scores were 
greater or less than ±1.96, respectively, in line with classical z statistical 
theory. We then used a univariate Kaplan-Meier survival analysis con-
ducted to test the effect of the levels of expression of each of the genes 
of interest (INTS6, INTS7, INTS8, INTS10, INTS11, and INTS12) on the 
overall survival (OS) of the patients that underwent chemotherapy 
treatment. In addition, we performed a multivariate Cox proportional 
hazards analysis to model the effects of age, stage, race, and gender 
along with the expression levels of the genes on the overall survival.
DNA microarray data (Affymetrix dataset) were downloaded from 
GEO database repository. The data downloaded were GSE33113, 
GSE39582, GSE9195, GSE6532, and GSE30161. They were pre-
processed using standard tools for microarray data normalization 
available through the Affy Package in R (42). Given the lack of normal 
samples in these data, differential expression was calculated, again, 
on the basis of the z score, assuming the global mean to represent the 
expression levels of normal samples. Kaplan-Meier survival analysis 
was conducted in a similar way to that described for TCGA data.
The bar plots shown in Fig. 7B represent the log2 FCs of INTS10 
and INTS11, and the corresponding FCs for NEAT1_2 among re-
spective samples. INTS10 and INTS11 “high” represents the samples 
for which the log FCs of the Integrator subunit is greater than 1.96 
(left panel), while INTS10 and INTS11 “low” represents log FC less 
than 1.96 (right panel). FCs were calculated using z scores (as de-
scribed above) to represent the classic null hypothesis of no overall 
FC in the mean of all samples. A weighted average of all the five 
NEAT1_2 Affymetrix probes was taken to represent the expression 
values for NEAT1_2.
Statistical analysis
The significance between means was determined by two-tailed paired 
Student’s t test or with a two-way analysis of variance (ANOVA) test. 
All P values are represented as follows: ns (not significant), *P < 0.05, 
**P < 0.01, ***P < 0.001, and ****P < 0.0001. All statistical analyses 
were performed with GraphPad Prism v7.0a.
Graphical output
Figure panels have been generated using Adobe Illustrator 22.1; sci-
entific illustrations were created with the online web-based software 
BioRender (https://biorender.com/) and iStock (www.istockphoto.com/).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/27/eaaz9072/DC1
View/request a protocol for this paper from Bio-protocol.
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